---
reference_id: "PMID:33037005"
title: Fast diagnostic test for familial Mediterranean fever based on a kinase inhibitor.
authors:
- Magnotti F
- Malsot T
- Georgin-Lavialle S
- Abbas F
- Martin A
- Belot A
- Fauter M
- Rabilloud M
- Gerfaud-Valentin M
- Sève P
- Duquesne A
- Hot A
- Durupt S
- Savey L
- Giurgea I
- Grateau G
- Henry T
- Jamilloux Y
journal: Ann Rheum Dis
year: '2021'
doi: 10.1136/annrheumdis-2020-218366
content_type: abstract_only
---

# Fast diagnostic test for familial Mediterranean fever based on a kinase inhibitor.
**Authors:** Magnotti F, Malsot T, Georgin-Lavialle S, Abbas F, Martin A, Belot A, Fauter M, Rabilloud M, Gerfaud-Valentin M, Sève P, Duquesne A, Hot A, Durupt S, Savey L, Giurgea I, Grateau G, Henry T, Jamilloux Y
**Journal:** Ann Rheum Dis (2021)
**DOI:** [10.1136/annrheumdis-2020-218366](https://doi.org/10.1136/annrheumdis-2020-218366)

## Content

1. Ann Rheum Dis. 2021 Jan;80(1):128-132. doi: 10.1136/annrheumdis-2020-218366. 
Epub 2020 Oct 9.

Fast diagnostic test for familial Mediterranean fever based on a kinase 
inhibitor.

Magnotti F(1), Malsot T(1), Georgin-Lavialle S(2)(3), Abbas F(4), Martin A(1), 
Belot A(1)(3)(5), Fauter M(6)(7), Rabilloud M(4), Gerfaud-Valentin M(6), Sève 
P(6), Duquesne A(5), Hot A(8), Durupt S(9), Savey L(2), Giurgea I(10), Grateau 
G(2)(3), Henry T(1), Jamilloux Y(11)(6).

Author information:
(1)Centre International de Recherche en Infectiologie (CIRI), Inserm U1111, 
Université Claude Bernard-Lyon 1, CNRS, Ecole Normale Supérieure de Lyon, Lyon, 
France.
(2)Internal Medicine, Tenon Hospital, AP-HP, Paris, France.
(3)CEREMAIA (Centre de Référence des Maladies Autoinflammatoires et des 
Amyloses), Paris, France.
(4)Biostatistics, Pôle de Santé Publique,CNRS UMR5308, Hospices Civils de Lyon, 
Lyon, France.
(5)Department of Paediatric Nephrology, Rheumatology, Dermatology, Hôpital 
Femme-Mère Enfant, Université Claude Bernard-Lyon 1, Hospices Civils de Lyon, 
Bron, France.
(6)Internal Medicine, University Hospital Croix-Rousse, Hospices Civils de Lyon, 
Lyon, France.
(7)Internal Medicine, Hospices Civils de Lyon, Lyon, France.
(8)Internal Medicine, University Hospital Edouard Herriot, Hospices Civils de 
Lyon, Lyon, France.
(9)Internal Medicine, University Hospital Lyon Sud, Hospices Civils de Lyon, 
Lyon, France.
(10)Genetics, Armand-Trousseau Hospital, APHP, Sorbonne University, Paris, 
Île-de-France, France.
(11)Centre International de Recherche en Infectiologie (CIRI), Inserm U1111, 
Université Claude Bernard-Lyon 1, CNRS, Ecole Normale Supérieure de Lyon, Lyon, 
France yvan.jamilloux@chu-lyon.fr.

BACKGROUND AND OBJECTIVE: Familial Mediterranean fever (FMF) is the most 
frequent hereditary autoinflammatory disease. Its diagnosis relies on a set of 
clinical criteria and a genetic confirmation on identification of biallelic 
pathogenic MEFV variants. MEFV encodes pyrin, an inflammasome sensor. Using a 
kinase inhibitor, UCN-01, we recently identified that dephosphorylation of 
FMF-associated pyrin mutants leads to inflammasome activation. The aim of this 
study was to assess whether quantifying UCN-01-mediated inflammasome activation 
could discriminate FMF patients from healthy donors (HD) and from patients with 
other inflammatory disorders (OID).
METHODS: Real-time pyroptosis and IL-1β secretion were monitored in response to 
UCN-01 in monocytes from FMF patients (n=67), HD (n=71) and OID patients (n=40). 
Sensitivity and specificity of the resulting diagnostic tests were determined by 
receiver operating characteristic curve analyses.
RESULTS: Inflammasome monitoring in response to UCN-01 discriminates FMF 
patients from other individuals. Pyroptosis assessment leads to a fast FMF 
diagnosis while combining pyroptosis and IL-1β dosage renders UCN-01-based 
assays highly sensitive and specific. UCN-01-triggered monocytes responses were 
influenced by MEFV gene dosage and MEFV mutations in a similar way as clinical 
phenotypes are.
CONCLUSIONS: UCN-01-based inflammasome assays could be used to rapidly diagnose 
FMF, with high sensitivity and specificity.

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and 
permissions. Published by BMJ.

DOI: 10.1136/annrheumdis-2020-218366
PMID: 33037005 [Indexed for MEDLINE]

Conflict of interest statement: Competing interests: YJ, FM, AB, AM and TH are 
coinventors and owners of a patent 'Methods and kits for diagnosis of familial 
Mediterranean fever' (WO/2019/048569).